QIXLEEF Trademark

Trademark Overview

On Wednesday, December 11, 2019, a trademark application was filed for QIXLEEF with the United States Patent and Trademark Office. The USPTO has given the QIXLEEF trademark a serial number of 88723399. The federal status of this trademark filing is ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE as of Tuesday, March 28, 2023. This trademark is owned by TETRA BIO-PHARMA INC.. The QIXLEEF trademark is filed in the Pharmaceutical Products and Medical Instrument Products categories with the following description:

Pharmaceutical preparations for pain relief in the field of advanced cancer and breakthrough pain

medical device namely vaporizers for medical purposes
qixleef

General Information

Serial Number88723399
Word MarkQIXLEEF
Filing DateWednesday, December 11, 2019
Status602 - ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE
Status DateTuesday, March 28, 2023
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Goods and ServicesPharmaceutical preparations for pain relief in the field of advanced cancer and breakthrough pain
Goods and Servicesmedical device namely vaporizers for medical purposes

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, December 16, 2019
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE
International Class010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials.
US Class Codes026, 039, 044
Class Status Code6 - Active
Class Status DateMonday, December 16, 2019
Primary Code010
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameTETRA BIO-PHARMA INC.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressLongueuil, Quebec J4H2X7
CA

Trademark Events

Event DateEvent Description
Wednesday, March 29, 2023ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
Tuesday, March 28, 2023ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
Tuesday, March 28, 2023ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Wednesday, September 7, 2022SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Wednesday, September 7, 2022NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Wednesday, September 7, 2022INQUIRY TO SUSPENSION E-MAILED
Wednesday, September 7, 2022SUSPENSION INQUIRY WRITTEN
Monday, March 7, 2022NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Monday, March 7, 2022LETTER OF SUSPENSION E-MAILED
Monday, March 7, 2022SUSPENSION LETTER WRITTEN
Tuesday, February 8, 2022TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, February 7, 2022CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, February 7, 2022TEAS RESPONSE TO OFFICE ACTION RECEIVED
Saturday, August 7, 2021NOTIFICATION OF NON-FINAL ACTION E-MAILED
Saturday, August 7, 2021NON-FINAL ACTION E-MAILED
Saturday, August 7, 2021NON-FINAL ACTION WRITTEN
Friday, July 30, 2021TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, July 30, 2021CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, July 30, 2021ASSIGNED TO LIE
Wednesday, July 28, 2021TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Thursday, February 18, 2021NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Thursday, February 18, 2021INQUIRY TO SUSPENSION E-MAILED
Thursday, February 18, 2021SUSPENSION INQUIRY WRITTEN
Tuesday, August 18, 2020NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Tuesday, August 18, 2020LETTER OF SUSPENSION E-MAILED
Tuesday, August 18, 2020SUSPENSION LETTER WRITTEN
Tuesday, July 28, 2020TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, July 27, 2020CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, July 27, 2020TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, January 28, 2020NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, January 28, 2020NON-FINAL ACTION E-MAILED
Tuesday, January 28, 2020NON-FINAL ACTION WRITTEN
Tuesday, January 28, 2020ASSIGNED TO EXAMINER
Monday, December 16, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Saturday, December 14, 2019NEW APPLICATION ENTERED

Related Keywords

qixleef pain medical device namely vaporizers purposes breakthrough cancer preparations relief